These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 6507516)

  • 1. Severe erythroblastosis fetalis secondary to anti-Kpb sensitization.
    Dacus JV; Spinnato JA
    Am J Obstet Gynecol; 1984 Dec; 150(7):888-9. PubMed ID: 6507516
    [No Abstract]   [Full Text] [Related]  

  • 2. Erythroblastosis fetalis produced by anti-k.
    Bowman JM; Harman FA; Manning CR; Pollock JM
    Vox Sang; 1989; 56(3):187-9. PubMed ID: 2728396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Kell antibodies in pregnancy].
    Rempen A; Schweppe KW
    Z Geburtshilfe Perinatol; 1983; 187(4):183-90. PubMed ID: 6684844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Death in utero due to Kell sensitization without excessive elevation of the delta OD450 value in amniotic fluid.
    Berkowitz RL; Beyth Y; Sadovsky E
    Obstet Gynecol; 1982 Dec; 60(6):746-9. PubMed ID: 7145281
    [No Abstract]   [Full Text] [Related]  

  • 5. Hemolytic disease of the newborn: progenitor cells and late effects.
    Luban NL
    N Engl J Med; 1998 Mar; 338(12):830-1. PubMed ID: 9504946
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hemolytic disease of the newborn due to anti-Ku (author's transl)].
    Huang HJ; Tagawa H
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Jan; 34(1):119-21. PubMed ID: 7199551
    [No Abstract]   [Full Text] [Related]  

  • 7. The second example of anti-K22 and a family genetically informative for K and K22.
    Manny N; Levene C; Harel N; Schneiderman S; Simon A; Daniels GL
    Vox Sang; 1985; 49(2):135-7. PubMed ID: 4036083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haemolytic disease of the newborn due to anti-k.
    Duguid JK; Bromilow IM
    Vox Sang; 1990; 58(1):69. PubMed ID: 2316215
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hemolytic disease of the newborn due to Kell sensitization].
    Beller U; Hochner-Celnikier D; Ron M; Palti Z; Beyth Y
    Harefuah; 1981 Jul; 101(1-2):14-5. PubMed ID: 7319365
    [No Abstract]   [Full Text] [Related]  

  • 10. [Serologic incompatibility and family planning].
    Matýsek P; Ungerová A; Cuprová M; Muchová M
    Cesk Gynekol; 1988 Aug; 53(7):497-9. PubMed ID: 3168017
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of erythroid progenitor cells by anti-Kell antibodies in fetal alloimmune anemia.
    Vaughan JI; Manning M; Warwick RM; Letsky EA; Murray NA; Roberts IA
    N Engl J Med; 1998 Mar; 338(12):798-803. PubMed ID: 9504940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alloimmunisation via previous transfusion places female Kpb-negative recipients at risk for having children with clinically significant hemolytic disease of the newborn.
    Gorlin JB; Kelly L
    Vox Sang; 1994; 66(1):46-8. PubMed ID: 8146981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The significance of anti-Kell sensitization in pregnancy.
    Mayne KM; Bowell PJ; Pratt GA
    Clin Lab Haematol; 1990; 12(4):379-85. PubMed ID: 2081378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Rapid and severe development of fetal hemolytic disease due to anti-Kell antibodies].
    Frère MC; Schaaps JP; Thoumsin H; Retz MC; Rif J; Rigo J; De Cortis T; Lambotte R; Senterre J; Sondag-Thull D
    Rev Med Liege; 1995 Feb; 50(2):63-6. PubMed ID: 7899747
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hemolytic disease of the newborn caused by maternal allo-immunization against erythrocyte antigens other than A, B and rhesus D].
    Monestier M; Rigal D; Juron-Dupraz F; Meyer F
    J Gynecol Obstet Biol Reprod (Paris); 1984; 13(6):671-80. PubMed ID: 6520354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chorionic biopsy in management of severe Kell alloimmunization.
    Rodesch F; Lambermont M; Donner C; Simon P; Romasco F; Schwers J; Wybran J
    Am J Obstet Gynecol; 1987 Jan; 156(1):124-5. PubMed ID: 3799745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythroblastosis fetalis with hydrops resulting from anti-Kell isoimmune disease.
    Frigoletto FD; Davies IJ
    Am J Obstet Gynecol; 1977 Apr; 127(8):887. PubMed ID: 851149
    [No Abstract]   [Full Text] [Related]  

  • 18. [Isoimmunization to Kell factor, during pregnancy].
    Krug A; Bianchi R; Cornejo A; Farias S; Fuentes L
    Rev Chil Obstet Ginecol; 1988; 53(4):198-200. PubMed ID: 3155245
    [No Abstract]   [Full Text] [Related]  

  • 19. Interdonor incompatibility due to anti-Kell antibody undetectable by automated antibody screening.
    West NC; Jenkins JA; Johnston BR; Modi N
    Vox Sang; 1986; 50(3):174-6. PubMed ID: 3716289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fetal death and benign hemolytic disease of the newborn from anti-Cellano alloimmunization: 2 new case reports].
    Rigal D; Juron-Dupraz F; Biggio B; Jouvenceaux A
    Rev Fr Transfus Immunohematol; 1982 Feb; 25(1):101-4. PubMed ID: 7071459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.